In this study, we evaluated the differentiation capacities by in vitro embryoid body (EB), in vivo teratoma, as well as an in vitro directed differentiation assay in Terc−/−, Terc+/−, and wild-type (Terc+/+) ntESCs. The gene discussed is TERC; the disease is teratoma.